Rethinking Our Approach to Value Assessment to Ensure the Patient Voice is Heard
According to a panel that featured NPC Chief Science Officer Robert W. Dubois and was summarized in a Value in Health article, even though value assessment frameworks are growing in use, these cost-effectiveness measurement tools are not ready for “prime time” as they leave out critical considerations, including the patient voice.
A white paper from NPC and Discern Health analyzes the landscape of available patient-reported measures and patient-reported performance measures in oncology, and offers recommendations for filling gaps in measures and removing barriers to measure implementation in accountable care programs.
NPC in Specialty Pharmacy Times: What's Really Behind Discrepancies in Coverage Decisions?
In his latest column for Specialty Pharmacy Times, National Pharmaceutical Council President and CEO Dan Leonard looks at what’s really behind the discrepancies in coverage decisions from one insurer to the next.